Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free HTGMQ Stock Alerts

HTG Molecular Diagnostics (HTGMQ) Competitors

Compare

HTGMQ vs. OLITW, PRENW, QSIAW, SMAPW, and TT

Should you be buying HTG Molecular Diagnostics stock or one of its competitors? The main competitors of HTG Molecular Diagnostics include OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), and Trane Technologies (TT). These companies are all part of the "measuring and control equipment" industry.

How does HTG Molecular Diagnostics compare to OmniLit Acquisition?

OmniLit Acquisition (NASDAQ:OLITW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both measuring and control equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings.

OmniLit Acquisition has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniLit AcquisitionN/AN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

Company Net Margins Return on Equity Return on Assets
OmniLit AcquisitionN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

In the previous week, OmniLit Acquisition's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
OmniLit Acquisition Neutral
HTG Molecular Diagnostics Neutral

Summary

HTG Molecular Diagnostics beats OmniLit Acquisition on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Prenetics Global?

Prenetics Global (NASDAQ:PRENW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

In the previous week, Prenetics Global's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
Prenetics Global Neutral
HTG Molecular Diagnostics Neutral

Prenetics Global has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$92.39MN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

Company Net Margins Return on Equity Return on Assets
Prenetics GlobalN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

Summary

Prenetics Global beats HTG Molecular Diagnostics on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Quantum-Si?

Quantum-Si (NASDAQ:QSIAW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

In the previous week, Quantum-Si's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
Quantum-Si Neutral
HTG Molecular Diagnostics Neutral

Quantum-Si has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quantum-Si$2.44MN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

Company Net Margins Return on Equity Return on Assets
Quantum-SiN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

Summary

HTG Molecular Diagnostics beats Quantum-Si on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to SportsMap Tech Acquisition?

SportsMap Tech Acquisition (NASDAQ:SMAPW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both measuring and control equipment companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Company Net Margins Return on Equity Return on Assets
SportsMap Tech AcquisitionN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

In the previous week, SportsMap Tech Acquisition's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
SportsMap Tech Acquisition Neutral
HTG Molecular Diagnostics Neutral

SportsMap Tech Acquisition has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SportsMap Tech AcquisitionN/AN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

Summary

HTG Molecular Diagnostics beats SportsMap Tech Acquisition on 1 of the 1 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Trane Technologies?

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and Trane Technologies (NYSE:TT) are both measuring and control equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

Trane Technologies has higher revenue and earnings than HTG Molecular Diagnostics. HTG Molecular Diagnostics is trading at a lower price-to-earnings ratio than Trane Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A
Trane Technologies$21.60B4.89$2.92B$12.9336.92

Trane Technologies has a net margin of 13.41% compared to HTG Molecular Diagnostics' net margin of 0.00%. Trane Technologies' return on equity of 35.55% beat HTG Molecular Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
Trane Technologies 13.41%35.55%13.73%

HTG Molecular Diagnostics has a beta of 3.25, meaning that its stock price is 225% more volatile than the S&P 500. Comparatively, Trane Technologies has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500.

Trane Technologies has a consensus target price of $505.56, indicating a potential upside of 5.91%. Given Trane Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Trane Technologies is more favorable than HTG Molecular Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HTG Molecular Diagnostics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Trane Technologies
1 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.61

83.0% of Trane Technologies shares are owned by institutional investors. 2.6% of HTG Molecular Diagnostics shares are owned by company insiders. Comparatively, 0.1% of Trane Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Trane Technologies had 42 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 42 mentions for Trane Technologies and 0 mentions for HTG Molecular Diagnostics. Trane Technologies' average media sentiment score of 1.03 beat HTG Molecular Diagnostics' score of 0.00 indicating that Trane Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
HTG Molecular Diagnostics Neutral
Trane Technologies Positive

Summary

Trane Technologies beats HTG Molecular Diagnostics on 14 of the 16 factors compared between the two stocks.

Get HTG Molecular Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HTGMQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTGMQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HTGMQ vs. The Competition

Export
MetricHTG Molecular DiagnosticsAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market CapN/A$92K$6.25B$11.87B
Dividend YieldN/AN/A2.73%5.21%
P/E Ratio0.00N/A29.0428.47
Price / SalesN/A0.00476.6160.92
Price / CashN/AN/A27.6236.52
Price / BookN/A0.369.676.67
Net Income-$21.59M-$47.72M$3.55B$332.53M

HTG Molecular Diagnostics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A90
OLITW
OmniLit Acquisition
N/A$1.63
-8.4%		N/AN/A$0.00N/AN/A3
PRENW
Prenetics Global
N/A$0.02
-12.3%		N/AN/A$0.00$92.39MN/A1
QSIAW
Quantum-Si
N/A$0.08
-9.4%		N/AN/A$0.00$2.44MN/A150
SMAPW
SportsMap Tech Acquisition
N/A$0.02
-32.8%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:HTGMQ) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel